ANGO vs HUM · rev $292.5M vs P/E 39, rev $129.66B
AngioDynamics Inc (ANGO) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
ANGO currently screens at market cap $378.5M. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the ANGO and HUM stock pages for the full models.
Not investment advice.